1. Mazaheri S, Rezaie A, Hosseinzadeh A. The ten years survey on clinical and epidemiologic features of guillian-barre syndrome in sina hospital, Hamadan, Iran. Journal of Research in health sciences. 2005;14(244:(56-60. (Persian) [
DOI]
2. Rahimi jaberi A, Manafi A, Mossallaiepoor A, Ebrahimi M M, Khazforoosh S, Shirazi zade mehraban S, et al . The Epidemiologic, Clinical and Laboratory Findings of Patients with Guillain Barre´ Syndrome in Southern Iran Since 2007 to 2012. J Fasa Univ Med Sci. 2014; 3 (4) :343-347. (Persian) [
DOI]
3. Esteghamati A, Gouya MM, Keshtkar AA, Mahoney F. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children. Vaccine. 2008;26(39):5058-61. [
DOI]
4. Rocha MS, Brucki SM, Carvalho A, Lima UW. Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arquivos de neuro-psiquiatria. 2004;62(1):33-7. [
DOI]
5. Tekgul H, Serdaroglu G, Tutuncuoglu S. Outcome of axonal and demyelinating forms of Guillain-Barré syndrome in children. Pediatric Neurology. 2003;28(4):295-9. [
DOI]
6. Farhoudi M, Ayromlou H, Bazzazi AM, Shadi FB, Golzari S, Ghabili K, et al. Time frequency of Guillain-Barre syndrome in northwest of Iran. Life Sci J. 2013;10(1):223-5. [
DOI]
7. Clinical and Laboratory Features of Childhood Guillain-Barre Syndrome Associated with Campylibacter Jejuni Infection. Pajoohandeh. 2010;14(6):307-12. (Persian) [
DOI]
8. Barzegar M, Farid SD, Dastgiri S, Malekian A, Toopchizadeh V. Childhood Guillian-barre syndromme in the iran east azerbaijan province: 2001-2005. Iranian Journal of Child Neurology. 2008;2(4):25-31. [
DOI]
9. Baxter R, Bakshi N, Fireman B, Lewis E, Ray P, Vellozzi C, et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clinical infectious diseases. 2013;57(2):197-204. [
DOI]
10. Huda MN, Khan MM, Azam B, Uddin MJ. Study of Cerebrospinal Fluid (CSF) and Clinical and Electrophysiological Features of Hospitalized Patients with Gullain-Barre´ Syndrome. Journal of Enam Medical College. 2015;5(3):145-50. [
DOI]
11. Arami MA, Yazdchi M, Khandaghi R. Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Annals of Saudi medicine. 2006;26(1):22. [
DOI]
12. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-33. [
DOI]
13. Xiong CH, Liao Z, Peng SH, Wen HR, Zhang YX, Chen SH, et al. Epidemiologic Characteristics of Guillain-Barre Syndrome in Nanchang China: a Retrospective Study. International Medical Journal. 2014;21(5):496-499. [
DOI]
14. Rocha MSG, Brucki SMD, Carvalho AA, Lima ÚWP. Epidemiologic features of guillain-barré syndrome in São Paulo, Brazil. Arquivos de neuro-psiquiatria. 2004;62(1):33-7. [
DOI]
15. Wakerley BR, Uncini A, Yuki N; GBS Classification Group. Guillain–Barré and Miller Fisher syndromes – new diagnostic classification". Nature Reviews Neurology.2014, 10 (9): 537–44. [
DOI]
16. 16. Shahrizaila, N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. Journal of Neurology, Neurosurgery & Psychiatry. 2012, 84 (5): 576–583. [
DOI]
17. Blum S, Reddel S, Spies J, McCombe P. Clinical features of patients with Guillain‐Barré syndrome at seven hospitals on the East Coast of Australia. Journal of the Peripheral Nervous System. 2013;18(4):316-20. [
DOI]
18. Ruiz E, Ramalle-Gómara E, Quiñones C, Martínez-Ochoa E. Trends in Guillain–Barré syndrome mortality in Spain from 1999 to 2013, International Journal of Neuroscience, 126:11, 985-988. [
DOI]
19. Chaudhuri JR, Alladi S, Mridula KR, Boddu DB, Rao M, Hemanth C, et al. Clinical outcome of Guillain-Barré syndrome with various treatment methods and cost effectiveness: A study from tertiary care center in South India: Yashoda GBS Registry. Neurology Asia 2014; 19(3): 263 – 270 [
DOI]
20. Anthony S, Fauci, Braunwald E, Kasper DL. Harrison`s Principles of Internal Medicine. 18th ed, New York: McGrawHill; 2012. 1783-8. [
DOI]